These results suggest that the EpC nanocarrier may repair the aberrant DNA methylation in cancer cells by co-delivering TET1 gene-encoding pDNA and 5-aza-dC and suppress cancer cell proliferation by promoting G2/M cell cycle arrest via p53 protein expression. The gene discussed is TP53; the disease is cancer.